Annual FCF
-$34.70 M
-$1.99 M-6.07%
31 December 2023
Summary:
Candel Therapeutics annual free cash flow is currently -$34.70 million, with the most recent change of -$1.99 million (-6.07%) on 31 December 2023. During the last 3 years, it has fallen by -$24.15 million (-229.01%). CADL annual FCF is now -550.32% below its all-time high of -$5.34 million, reached on 31 December 2019.CADL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$6.57 M
-$369.00 K-5.95%
30 September 2024
Summary:
Candel Therapeutics quarterly free cash flow is currently -$6.57 million, with the most recent change of -$369.00 thousand (-5.95%) on 30 September 2024. Over the past year, it has increased by +$2.34 million (+26.24%). CADL quarterly FCF is now -196.88% below its all-time high of -$2.21 million, reached on 31 March 2020.CADL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$28.69 M
+$2.34 M+7.53%
30 September 2024
Summary:
Candel Therapeutics TTM free cash flow is currently -$28.69 million, with the most recent change of +$2.34 million (+7.53%) on 30 September 2024. Over the past year, it has increased by +$5.70 million (+16.58%). CADL TTM FCF is now -1195.89% below its all-time high of -$2.21 million, reached on 31 March 2020.CADL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CADL Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.1% | +26.2% | +16.6% |
| 3 y3 years | -229.0% | +9.8% | -29.4% |
| 5 y5 years | - | - | - |
CADL Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -229.0% | at low | -14.5% | +40.0% | -29.4% | +19.1% |
| 5 y | 5 years | -550.3% | at low | -196.9% | +40.0% | -1195.9% | +19.1% |
| alltime | all time | -550.3% | at low | -196.9% | +40.0% | -1195.9% | +19.1% |
Candel Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.57 M(+5.9%) | -$28.69 M(-7.5%) |
| June 2024 | - | -$6.20 M(-26.5%) | -$31.03 M(-3.6%) |
| Mar 2024 | - | -$8.45 M(+13.1%) | -$32.19 M(-7.2%) |
| Dec 2023 | -$34.70 M(+6.1%) | -$7.47 M(-16.2%) | -$34.70 M(+0.9%) |
| Sept 2023 | - | -$8.91 M(+21.0%) | -$34.39 M(-2.0%) |
| June 2023 | - | -$7.36 M(-32.8%) | -$35.08 M(-1.0%) |
| Mar 2023 | - | -$10.96 M(+53.0%) | -$35.45 M(+8.4%) |
| Dec 2022 | -$32.72 M | -$7.16 M(-25.4%) | -$32.72 M(+4.5%) |
| Sept 2022 | - | -$9.60 M(+24.1%) | -$31.30 M(+8.0%) |
| June 2022 | - | -$7.73 M(-6.0%) | -$28.98 M(+9.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$8.22 M(+43.2%) | -$26.42 M(+9.8%) |
| Dec 2021 | -$24.05 M(+128.1%) | -$5.74 M(-21.2%) | -$24.05 M(+8.4%) |
| Sept 2021 | - | -$7.29 M(+41.0%) | -$22.18 M(+29.5%) |
| June 2021 | - | -$5.17 M(-11.7%) | -$17.13 M(+20.7%) |
| Mar 2021 | - | -$5.86 M(+51.4%) | -$14.19 M(+34.5%) |
| Dec 2020 | -$10.55 M(+97.7%) | -$3.87 M(+73.4%) | -$10.55 M(+57.9%) |
| Sept 2020 | - | -$2.23 M(-0.1%) | -$6.68 M(+50.2%) |
| June 2020 | - | -$2.23 M(+0.9%) | -$4.45 M(+100.9%) |
| Mar 2020 | - | -$2.21 M | -$2.21 M |
| Dec 2019 | -$5.34 M | - | - |
FAQ
- What is Candel Therapeutics annual free cash flow?
- What is the all time high annual FCF for Candel Therapeutics?
- What is Candel Therapeutics annual FCF year-on-year change?
- What is Candel Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Candel Therapeutics?
- What is Candel Therapeutics quarterly FCF year-on-year change?
- What is Candel Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Candel Therapeutics?
- What is Candel Therapeutics TTM FCF year-on-year change?
What is Candel Therapeutics annual free cash flow?
The current annual FCF of CADL is -$34.70 M
What is the all time high annual FCF for Candel Therapeutics?
Candel Therapeutics all-time high annual free cash flow is -$5.34 M
What is Candel Therapeutics annual FCF year-on-year change?
Over the past year, CADL annual free cash flow has changed by -$1.99 M (-6.07%)
What is Candel Therapeutics quarterly free cash flow?
The current quarterly FCF of CADL is -$6.57 M
What is the all time high quarterly FCF for Candel Therapeutics?
Candel Therapeutics all-time high quarterly free cash flow is -$2.21 M
What is Candel Therapeutics quarterly FCF year-on-year change?
Over the past year, CADL quarterly free cash flow has changed by +$2.34 M (+26.24%)
What is Candel Therapeutics TTM free cash flow?
The current TTM FCF of CADL is -$28.69 M
What is the all time high TTM FCF for Candel Therapeutics?
Candel Therapeutics all-time high TTM free cash flow is -$2.21 M
What is Candel Therapeutics TTM FCF year-on-year change?
Over the past year, CADL TTM free cash flow has changed by +$5.70 M (+16.58%)